Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

PRAVEEN AKUTHOTA

Allopathic & Osteopathic Physicians Internal Medicine Critical Care Medicine

NPI
1396704698
CMS profile
108677
Location
SAN DIEGO, CA

General Payments · PY2018–2024

$151,920.60

  • Reported across 143 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$24,995.91

28 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $13,020.93 14
GlaxoSmithKline, LLC. $5,850.00 1
AstraZeneca AB $4,698.75 3
AstraZeneca UK Limited $1,426.23 10

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $27,100.04 33
PY2019 $24,232.05 32
PY2020 $21,976.81 21
PY2021 $5,422.75 2
PY2022 $5,040.40 7
PY2023 $43,152.64 20
PY2024 $24,995.91 28

Payment records · PY2024 (28)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca AB $2,416.50 09/03/2024 Consulting Fee Undisputed 01/23/2026 1093938322 CMS
AstraZeneca AB $1,745.25 09/03/2024 Consulting Fee Undisputed 01/23/2026 1093941153 CMS
AstraZeneca AB $537.00 12/02/2024 Consulting Fee Undisputed 01/23/2026 1093982750 CMS
AstraZeneca Pharmaceuticals LP $1,074.00 01/12/2024 Consulting Fee Undisputed 01/23/2026 1105852090 CMS
AstraZeneca Pharmaceuticals LP $32.45 03/15/2024 Food and Beverage Undisputed 01/23/2026 1104642635 CMS
AstraZeneca Pharmaceuticals LP $122.47 04/18/2024 Food and Beverage Undisputed 01/23/2026 1105603018 CMS
AstraZeneca Pharmaceuticals LP $3,222.00 05/27/2024 Consulting Fee Undisputed 01/23/2026 1104476210 CMS
AstraZeneca Pharmaceuticals LP $2,150.00 06/28/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1104574726 CMS
AstraZeneca Pharmaceuticals LP $1,342.50 09/02/2024 Consulting Fee Undisputed 01/23/2026 1104442825 CMS
AstraZeneca Pharmaceuticals LP $81.50 09/09/2024 Food and Beverage Undisputed 01/23/2026 1104692032 CMS
AstraZeneca Pharmaceuticals LP $18.98 09/09/2024 Food and Beverage Undisputed 01/23/2026 1105207461 CMS
AstraZeneca Pharmaceuticals LP $27.47 10/30/2024 Food and Beverage Undisputed 01/23/2026 1104401065 CMS
AstraZeneca Pharmaceuticals LP $1,879.50 11/15/2024 Consulting Fee Undisputed 01/23/2026 1105827489 CMS
AstraZeneca Pharmaceuticals LP $2,148.00 11/27/2024 Consulting Fee Undisputed 01/23/2026 1105695400 CMS
AstraZeneca Pharmaceuticals LP $537.00 12/03/2024 Consulting Fee Undisputed 01/23/2026 1104716695 CMS
AstraZeneca Pharmaceuticals LP $85.06 12/10/2024 Food and Beverage Undisputed 01/23/2026 1105785092 CMS
AstraZeneca Pharmaceuticals LP $300.00 12/24/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1105731597 CMS
AstraZeneca UK Limited $91.69 05/18/2024 Food and Beverage Undisputed 01/23/2026 1093998179 CMS
AstraZeneca UK Limited $19.62 05/22/2024 Food and Beverage Undisputed 01/23/2026 1093894444 CMS
AstraZeneca UK Limited $36.05 09/23/2024 Food and Beverage Undisputed 01/23/2026 1093894590 CMS
AstraZeneca UK Limited $110.43 09/23/2024 Food and Beverage Undisputed 01/23/2026 1093921795 CMS
AstraZeneca UK Limited $50.15 09/23/2024 Food and Beverage Undisputed 01/23/2026 1093939761 CMS
AstraZeneca UK Limited $18.84 09/23/2024 Food and Beverage Undisputed 01/23/2026 1093941706 CMS
AstraZeneca UK Limited $613.94 09/23/2024 Travel and Lodging Undisputed 01/23/2026 1093954679 CMS
AstraZeneca UK Limited $38.71 09/23/2024 Food and Beverage Undisputed 01/23/2026 1094009755 CMS
AstraZeneca UK Limited $362.74 09/23/2024 Travel and Lodging Undisputed 01/23/2026 1094039886 CMS
AstraZeneca UK Limited $84.06 09/23/2024 Travel and Lodging Undisputed 01/23/2026 1094044128 CMS
GlaxoSmithKline, LLC. $5,850.00 03/28/2024 Consulting Fee Undisputed 01/23/2026 1116201439 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.